Qualitative Assessment of Advanced MRI in Post-Treatment High Grade Gliomas Follow Up: Do We Agree?

Nader Zakhari1, Michael Taccone2, Carlos Torres1,3

  • 1Division of Neuroradiology, Department of Radiology, University of Ottawa, The Ottawa Hospital Civic and General Campus, Ottawa, Ontario, Canada.

Abstract

Insights

Quantitative MRI measurements show good agreement for high-grade glioma follow-up, unlike qualitative assessments. Relying solely on visual interpretation of enhancement patterns and diffusion restriction may hinder accurate diagnosis of glioma recurrence.

Area of Science:

  • Radiology
  • Neuro-oncology
  • Medical Imaging

Background:

  • High-grade glioma (HGG) management requires accurate follow-up imaging.
  • Magnetic Resonance Imaging (MRI) is crucial for monitoring treatment response and detecting recurrence.
  • Advanced MRI techniques, including diffusion-weighted imaging (DWI) and dynamic contrast-enhanced (DCE) and dynamic susceptibility contrast (DSC) perfusion imaging, are increasingly utilized.

Purpose of the Study:

  • To evaluate the interrater agreement of qualitative visual assessments for various conventional and advanced MR techniques in treated HGG.
  • To compare the reliability of qualitative assessments with established quantitative measurements.
  • To determine the utility of these MR techniques in differentiating tumor recurrence from treatment-related changes.

Main Methods:

  • Prospective enrollment of HGG patients undergoing resection of new enhancing lesions on post-treatment 3T MRI.
  • Inclusion of DWI, DCE, and DSC sequences.
  • Objective assessment of diffusion and perfusion maps by two neuroradiologists using regions of interest (ROIs).
  • Subjective assessment of post-contrast, perfusion, and diffusion sequences.
  • Calculation of interrater agreement (kappa statistic) and concordance correlation coefficient (ρc).

Main Results:

  • Quantitative measurements demonstrated substantial to moderate interrater agreement for AUC (ρc=0.98) and Vp (ρc=0.97), and moderate agreement for k-trans and corrected CBV (ρc=0.94).
  • Qualitative assessments showed variable interrater agreement, ranging from good for k-trans (k=0.73) to poor for enhancement pattern (k=0.02) and diffusion restriction (k=0.07).
  • Quantitative measurements for Ve and ADC showed poor concordance (ρc=0.86 and 0.24, respectively).

Conclusions:

  • Quantitative measurements of DSC and DCE perfusion maps exhibit satisfactory interrater agreement, supporting their use in HGG follow-up.
  • Qualitative assessments, particularly for enhancement patterns and diffusion restriction, have lower interobserver agreement and should not be solely relied upon.
  • Suboptimal inter-rater agreement in qualitative interpretation may limit the ability to reliably differentiate glioma recurrence from treatment effects.

Related Concept Videos